NO20002505L - <Alfa>-hydroksy, -amin og -fluor derivater av <beta>- sulfonylhydroksamsyrer som matriks metallproteinaseinhibitorer - Google Patents

<Alfa>-hydroksy, -amin og -fluor derivater av <beta>- sulfonylhydroksamsyrer som matriks metallproteinaseinhibitorer

Info

Publication number
NO20002505L
NO20002505L NO20002505A NO20002505A NO20002505L NO 20002505 L NO20002505 L NO 20002505L NO 20002505 A NO20002505 A NO 20002505A NO 20002505 A NO20002505 A NO 20002505A NO 20002505 L NO20002505 L NO 20002505L
Authority
NO
Norway
Prior art keywords
unsubstituted
substituted
alfa
beta
hydroxy
Prior art date
Application number
NO20002505A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002505D0 (no
Inventor
Martha A Warpehoski
Mark Allen Mitchell
Donald E Harper
Linda Louise Maggiora
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20002505D0 publication Critical patent/NO20002505D0/no
Publication of NO20002505L publication Critical patent/NO20002505L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO20002505A 1997-11-21 2000-05-15 <Alfa>-hydroksy, -amin og -fluor derivater av <beta>- sulfonylhydroksamsyrer som matriks metallproteinaseinhibitorer NO20002505L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7265597P 1997-11-21 1997-11-21
PCT/IB1998/002154 WO1999026909A2 (en) 1997-11-21 1998-11-18 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors

Publications (2)

Publication Number Publication Date
NO20002505D0 NO20002505D0 (no) 2000-05-15
NO20002505L true NO20002505L (no) 2000-06-30

Family

ID=22108985

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002505A NO20002505L (no) 1997-11-21 2000-05-15 <Alfa>-hydroksy, -amin og -fluor derivater av <beta>- sulfonylhydroksamsyrer som matriks metallproteinaseinhibitorer

Country Status (24)

Country Link
US (2) US20030166687A1 (bg)
EP (1) EP1037868B1 (bg)
JP (1) JP2001524462A (bg)
KR (1) KR20010032319A (bg)
CN (1) CN1168709C (bg)
AT (1) ATE232192T1 (bg)
AU (1) AU763113B2 (bg)
BG (1) BG104346A (bg)
BR (1) BR9814699A (bg)
CA (1) CA2310401A1 (bg)
DE (1) DE69811273T2 (bg)
DK (1) DK1037868T3 (bg)
EA (1) EA003585B1 (bg)
ES (1) ES2192349T3 (bg)
HU (1) HUP0100812A3 (bg)
IL (1) IL135586A0 (bg)
IS (1) IS1954B (bg)
NO (1) NO20002505L (bg)
NZ (1) NZ503997A (bg)
PL (1) PL341153A1 (bg)
PT (1) PT1037868E (bg)
TR (1) TR200001391T2 (bg)
UA (1) UA66818C2 (bg)
WO (1) WO1999026909A2 (bg)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA66818C2 (uk) * 1997-11-21 2004-06-15 Фармація Енд Апджон Компані <font face="Symbol">a</font>-ГІДРОКСИ, АМІНО- ТА ГАЛОПОХІДНІ <font face="Symbol">b</font>-СУЛЬФОНІЛГІДРОКСАМОВИХ КИСЛОТ, ПОХІДНІ ПРОПІОНОВОЇ КИСЛОТИ, СПОСІБ ІНГІБУВАННЯ МАТРИЧНИХ МЕТАЛОПРОТЕЇНАЗ, СПОСІБ ЛІКУВАННЯ ЛЮДИНИ, ЩО СТРАЖДАЄ ВІД АБО ЧУТЛИВОЇ ДО ХВОРОБИ, ПОВ'ЯЗАНОЇ З РУЙНУВАННЯМ СПОЛУЧНОЇ ТКАНИНИ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ
GB9927453D0 (en) * 1999-11-19 2000-01-19 Pharmacia & Upjohn Spa Crystalline and optically active form of a-hydroxy derivatives of ›-sulfonyl acid
EP2292593A3 (en) * 2000-09-29 2011-05-25 TopoTarget UK Limited Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
ES2257441T3 (es) * 2000-09-29 2006-08-01 Topotarget Uk Limited Compuestos de acido carbonico que comprenden un enlace amino como inhibidores hdac.
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
DE10320453A1 (de) * 2003-05-08 2004-11-25 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Bioisostere von Actinonin
JP2009519349A (ja) * 2005-12-15 2009-05-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を変調する化合物
WO2008014199A2 (en) * 2006-07-28 2008-01-31 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the cb2 receptor
CA2664310A1 (en) * 2006-09-25 2008-04-03 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US7539361B2 (en) * 2006-10-05 2009-05-26 Harris Corporation Fiber optic device for measuring a parameter of interest
DE102006049618A1 (de) * 2006-10-20 2008-05-08 Tschesche, Harald, Prof. Dr. Triazine und Ihre Verwendung als Metalloproteinase-Inhibitoren
WO2009061652A1 (en) * 2007-11-07 2009-05-14 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US8178568B2 (en) * 2008-07-10 2012-05-15 Boehringer Ingelheim International Gmbh Sulfone compounds which modulate the CB2 receptor
CA2737639A1 (en) * 2008-09-25 2010-04-01 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the cb2 receptor
US8299103B2 (en) 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
EP2443107B1 (en) 2009-06-16 2018-08-08 Boehringer Ingelheim International GmbH Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
JP2013505295A (ja) * 2009-09-22 2013-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を選択的に調節する化合物
JP2013517271A (ja) 2010-01-15 2013-05-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を調節する化合物
EP2542539B1 (en) 2010-03-05 2014-02-26 Boehringer Ingelheim International GmbH Tetrazole compounds which selectively modulate the cb2 receptor
JP5746764B2 (ja) 2010-07-22 2015-07-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を調節する化合物
EP2803668A1 (en) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
EP3628661A1 (en) * 2013-06-27 2020-04-01 Lg Chem, Ltd. Biaryl derivatives as gpr120 agonists
US11072583B2 (en) 2017-11-27 2021-07-27 Council Of Scientific & Industrial Research Indole (sulfomyl) n-hydroxy benzamide derivatives as selective HDAC inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2183905T3 (es) * 1995-12-20 2003-04-01 Hoffmann La Roche Inhibidores de metaloproteasa de matriz.
EP0871439B1 (en) 1996-01-02 2004-03-31 Aventis Pharmaceuticals Inc. Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
WO1997049679A1 (fr) 1996-06-27 1997-12-31 Ono Pharmaceutical Co., Ltd. Derives d'aryle (sulfure, oxyde sulfonique et sulfone) et medicaments les contenant en tant que principe actif
CA2263154A1 (en) 1996-08-07 1998-02-12 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
CA2266368A1 (en) * 1996-09-27 1998-04-02 Pharmacia & Upjohn Company .beta.-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors
EP0960096B1 (en) * 1997-01-22 2005-04-06 Aventis Pharmaceuticals Inc. Substituted beta-thiocarboxylic acids
JP2000507975A (ja) 1997-02-07 2000-06-27 ファイザー・インク Ｎ−ヒドロキシ−β−スルホニルプロピオンアミド誘導体類及びそれらのマトリックスメタロプロテイナーゼ阻害薬としての使用
KR20000075955A (ko) * 1997-03-04 2000-12-26 죤 에이치. 뷰센 방향족 술포닐 알파-히드록시 히드록삼산 화합물
US6362183B1 (en) * 1997-03-04 2002-03-26 G. D. Searle & Company Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
UA66818C2 (uk) * 1997-11-21 2004-06-15 Фармація Енд Апджон Компані <font face="Symbol">a</font>-ГІДРОКСИ, АМІНО- ТА ГАЛОПОХІДНІ <font face="Symbol">b</font>-СУЛЬФОНІЛГІДРОКСАМОВИХ КИСЛОТ, ПОХІДНІ ПРОПІОНОВОЇ КИСЛОТИ, СПОСІБ ІНГІБУВАННЯ МАТРИЧНИХ МЕТАЛОПРОТЕЇНАЗ, СПОСІБ ЛІКУВАННЯ ЛЮДИНИ, ЩО СТРАЖДАЄ ВІД АБО ЧУТЛИВОЇ ДО ХВОРОБИ, ПОВ'ЯЗАНОЇ З РУЙНУВАННЯМ СПОЛУЧНОЇ ТКАНИНИ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ

Also Published As

Publication number Publication date
AU2540599A (en) 1999-06-15
DK1037868T3 (da) 2003-05-12
AU763113B2 (en) 2003-07-10
US20030166687A1 (en) 2003-09-04
EA200000551A1 (ru) 2000-10-30
BR9814699A (pt) 2000-10-03
WO1999026909A3 (en) 1999-08-26
DE69811273T2 (de) 2003-12-11
CN1168709C (zh) 2004-09-29
IS1954B (is) 2004-10-13
HUP0100812A3 (en) 2002-11-28
IS5475A (is) 2000-04-28
TR200001391T2 (tr) 2000-11-21
CA2310401A1 (en) 1999-06-03
KR20010032319A (ko) 2001-04-16
WO1999026909A2 (en) 1999-06-03
HUP0100812A2 (hu) 2001-08-28
NZ503997A (en) 2001-09-28
IL135586A0 (en) 2001-05-20
JP2001524462A (ja) 2001-12-04
EP1037868B1 (en) 2003-02-05
EP1037868A2 (en) 2000-09-27
US6437177B1 (en) 2002-08-20
BG104346A (bg) 2001-01-31
NO20002505D0 (no) 2000-05-15
ES2192349T3 (es) 2003-10-01
ATE232192T1 (de) 2003-02-15
PT1037868E (pt) 2003-06-30
EA003585B1 (ru) 2003-06-26
CN1278247A (zh) 2000-12-27
DE69811273D1 (de) 2003-03-13
UA66818C2 (uk) 2004-06-15
PL341153A1 (en) 2001-03-26

Similar Documents

Publication Publication Date Title
NO20002505L (no) &lt;Alfa&gt;-hydroksy, -amin og -fluor derivater av &lt;beta&gt;- sulfonylhydroksamsyrer som matriks metallproteinaseinhibitorer
GEP20074166B (en) Acetyl 2-hydroxy-1,3 diaminoalkanes
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
NO991494D0 (no) &lt;beta&gt;-sulfonylhydroksaminsyrer som matriksmetalloproteinaseinhibitorer
BR9401482A (pt) 1H-Indol-3-acetamida, formulação farmacêutica, utilização de um composto e processo para a preparação de 1h-indol-3-acetamida
BR0206943A (pt) Inibidores de fosfodiesterase 4
CR11263A (es) COMPUESTOS NOVEDOSOS QUE POSEEN ACTIVIDAD INNHIBITORIA CONTRA TRANSPORTADOR DE GLUCOSA DEPENDIENTE DE SODIO (Solicitud divisional)
ATE272633T1 (de) Aromatische amiden
WO1999000373A8 (fr) Derives de benzimidazole
AR012603A1 (es) Inhibidor de proteasa, composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento; e intermediarios de sintesis
ES2191985T3 (es) S-oxido de tetrahidrotiopirano feniloxazolidinonas.
WO2002028844A1 (fr) Dérivés thiazole ou oxazole
ATE268751T1 (de) Biphenylamidin-derivate
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
CA2214386A1 (en) Optically active thiazolidinone derivatives
ATE293616T1 (de) 2-fluoro-(oxido-thiopyran-4-yl)benzol derivate
ES2131015A1 (es) Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
SV1998000088A (es) Compuestos farmaceuticos
MXPA04003086A (es) Proceso para sintesis estereoselectiva de 2-hidroximetil-cromanos.
BR9305752A (pt) Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona
NO981689L (no) Naftylpiperasinderivater
BR0203426A (pt) Processo para preparação dos compostos 2-(4-alquil-1-piperazinil)-benzaldeìdo e -benzilidenila
TH36107A (th) สารประกอบชนิดใหม่
ECSP982805A (es) Compuestos de tiourea y benzamida, composiciones y metodos para tratar y prevenir enfermedades inflamatorias y aterosclerosis